CAMP4 Therapeutics Corporation (CAMP) vs Niagen Bioscience, Inc. (NAGE)
CAMP4 Therapeutics Corporation and Niagen Bioscience, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Niagen Bioscience, Inc. are of similar size ($241.0M and $238.2M). CAMP4 Therapeutics Corporation has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 15.2×. Niagen Bioscience, Inc. has the higher net margin (12.4% vs −2,543.7%) and the higher return on invested capital (42.0% vs 0.00%). Across the 14 metrics below, Niagen Bioscience, Inc. leads on 13 and CAMP4 Therapeutics Corporation on 1.
Valuation
Profitability
| Metric | CAMP | NAGE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 64.24% | 65.16% |
| Operating margin | (1,254.22%) | 8.21% | 0.00% |
| Net margin | (2,543.74%) | 12.39% | 0.00% |
| Free cash flow margin | (680.36%) | 8.89% | 0.00% |
| Return on equity | (545.85%) | 21.80% | (57.72%) |
| Return on assets | (148.23%) | 16.14% | (49.22%) |
| Return on invested capital | 0.00% | 41.95% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack